 | Up a level |
Basu, Anirban, Prabhu, Vimalanand S., Dorr, Mary Beth, Golan, Yoav, Dubberke, Erik R., Cornely, Oliver A., Heimann, Sebastian M., Pedley, Alison, Xu, Ruifeng, Hanson, Mary E. and Marcella, Stephen (2018). Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials. Open Forum Infect. Dis., 5 (11). CARY: OXFORD UNIV PRESS INC. ISSN 2328-8957
Bouza, Emilio, Cornely, Oliver A., Ramos-Martinez, Antonio 
ORCID: 0000-0002-4840-9425, Plesniak, Robert, Ellison, Misoo C., Hanson, Mary E. and Dorr, Mary Beth
(2020).
Analysis of C. difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials.
Eur. J. Clin. Microbiol. Infect. Dis., 39 (10).
S. 1933 - 1940.
NEW YORK:
SPRINGER.
ISSN 1435-4373
Prabhu, Vimalanand S., Cornely, Oliver A., Golan, Yoav, Dubberke, Erik R., Heimann, Sebastian M., Hanson, Mary E., Liao, Jane, Pedley, Alison, Dorr, Mary Beth and Marcella, Stephen (2017). Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection. Clin. Infect. Dis., 65 (7). S. 1218 - 1222. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591